From: Epidemiology of childhood and adolescent cancer in Bangladesh, 2001–2014
Period of diagnosis | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
2001–2006 | 2007–2010 | 2011–2014 | ||||||||
ICCC diagnostic group | N | % | ASRa | N | % | ASRa | N | % | ASRa | M:F ratio |
Total | 455 | 2.0 | 988 | 5.1 | 1474 | 7.8 | 2.0:1 | |||
I Leukaemia | 269 | 59.1 | 1.2 | 264 | 26.7 | 1.4 | 271 | 18.4 | 1.4 | 3.2:1 |
ALL | 226 | 212 | 234 | |||||||
AML | 18 | 38 | 29 | |||||||
II Lymphoma | 89 | 19.6 | 0.4 | 237 | 24.0 | 1.2 | 115 | 7.8 | 0.6 | 2.7:1 |
Hodgkin lymphoma | 7 | 74 | 22 | |||||||
Non-Hodgkin lymphoma | 31 | 121 | 68 | |||||||
III CNS tumours | – | – | – | 5 | 0.5 | 0.03 | 65 | 4.4 | 0.3 | 1.5:1 |
Ependymoma | – | – | 15 | |||||||
Astrocytoma | – | – | 16 | |||||||
Medulloblastoma | – | – | 16 | |||||||
IV Neuroblastoma | 17 | 3.7 | 0.08 | 24 | 2.4 | 0.1 | 54 | 3.7 | 0.3 | 1.0:1 |
V Retinoblastoma | 6 | 1.3 | 0.03 | 74 | 7.5 | 0.4 | 374 | 25.4 | 2.1 | 1.8:1 |
VI Renal tumours | 27 | 5.9 | 0.2 | 95 | 9.6 | 0.5 | 90 | 6.1 | 0.5 | 2.1:1 |
Nephroblastoma | 25 | 87 | 89 | |||||||
VII Hepatic tumours | 8 | 1.8 | 0.04 | 13 | 1.3 | 0.07 | 29 | 2.0 | 0.2 | 3.8:1 |
Hepatoblastoma | 8 | 13 | 29 | |||||||
VIII Bone tumours | 2 | 0.4 | 0.01 | 60 | 6.1 | 0.3 | 175 | 11.9 | 0.9 | 1.6:1 |
Osteosarcoma | 1 | 38 | 91 | |||||||
Chondrosarcoma | – | – | 4 | |||||||
Ewing tumour | 1 | 22 | 79 | |||||||
IX Soft tissue sarcomas | 18 | 4.0 | 0.09 | 45 | 4.6 | 0.2 | 101 | 6.9 | 0.5 | 2.0:1 |
Rhabdomyosarcoma | 18 | 34 | 74 | |||||||
Fibrosarcoma | – | 3 | 14 | |||||||
X Germ cell and gonadal tumours | 7 | 1.5 | 0.03 | 117 | 11.8 | 0.6 | 125 | 8.5 | 0.6 | 1.2:1 |
XI Other epithelial tumours | 3 | 0.7 | 0.01 | 36 | 3.6 | 0.2 | 52 | 3.5 | 0.3 | 2.7:1 |
Nasopharyngeal carcinoma | 1 | 18 | 13 | |||||||
XII Other and unspecified tumours | 9 | 2.0 | 0.04 | 18 | 1.8 | 0.09 | 23 | 1.6 | 0.1 | 1.6:1 |